Rate My Professor Helen Cooper

Professor Helen Cooper serves as Interim Director and Deputy Director (Research) of the Queensland Brain Institute at the University of Queensland, where she leads the Neural Migration Laboratory as an inaugural Group Leader since 2003. She obtained her PhD in Biochemistry and Molecular Biology from the University of Melbourne, completed a postdoctoral fellowship at the Scripps Research Institute in San Diego, and established independent laboratories at the Ludwig Institute for Cancer Research and the Walter and Eliza Hall Institute in Melbourne prior to joining UQ. Her research investigates the fundamental cellular and molecular mechanisms shaping neocortical development, with a focus on axon guidance receptors Neogenin and Ryk. These receptors play critical roles in neural stem cell function, neurogenesis, dendrite outgrowth, synaptogenesis, and ependymal cell maturation. Disruptions in their signaling pathways result in cortical malformations such as heterotopias and hydrocephalus, mirroring human conditions and linking to neurodevelopmental disorders including autism, schizophrenia, epilepsy, and intellectual disability.

The Cooper laboratory employs mouse models, human induced pluripotent stem cell-derived neural cells, and advanced imaging to elucidate these processes, revealing novel functions in progenitor polarity, circuit formation, and spine morphogenesis. Key publications include 'BDNF-dependent nano-organization of Neogenin and the WAVE regulatory complex promotes actin remodeling in dendritic spines' (iScience, 2024), 'RGMa and Neogenin control dendritic spine morphogenesis via WAVE Regulatory Complex-mediated actin remodeling' (Frontiers in Molecular Neuroscience, 2023), 'DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formation' (eLife, 2021), 'Conservation of neural progenitor identity and the emergence of neocortical neuronal diversity' (Seminars in Cell & Developmental Biology, 2021), and 'The Wnt Receptor Ryk Is Required for Wnt5a-Mediated Axon Guidance' (Journal of Neuroscience, 2006). Professor Cooper has received extensive funding from NHMRC, including IDEAS Grants for autism gene networks (2021-2024) and spine morphogenesis (2020-2024), Project Grants on hydrocephalus and cortical malformations, and ARC Discovery Projects. In 2016, her work was selected by NHMRC as one of Australia's top 10 medical research projects, underscoring her impact on understanding brain development and disease origins.